Mesenchymal stem cells improve cardiac function after myocardial infarction in rats without long-term survival: a serial 7.0T MRI study by unknown
POSTER PRESENTATION Open Access
Mesenchymal stem cells improve cardiac function
after myocardial infarction in rats without
long-term survival: a serial 7.0T MRI study
Xiuyu Chen
From 18th Annual SCMR Scientific Sessions
Nice, France. 4-7 February 2015
Background
Bone marrow derivedmesenchymal stem cells (MSCs)
are a promising approach to the treatment of cardiac
injury after myocardial infarction (MI). However, little is
known about the underlying mechanisms and the fate of
the transplanted cells.Our aim was to in vivo monitoring
the magnetically labeled MSCs after transplantation into
infarcted rat hearts and determining the effects on car-
diac function using a 7.0 T magnetic resonance imaging
(MRI) scanner.
Methods
Rat MSCs (male) were dual-labeled with fluorescent
micron-sized particles of iron oxide (MPIO) and CM-
DiI. Seven days after MI, rats (syngeneic females) were
randomized to injections of labeled MSCs (2×106 cells/
50μL) or saline (50μL) into the border zone of infarcted
myocardium. MRI was used to evaluate stem cell migra-
tion, signal intensity changes and cardiac function at
baseline (1 day before transplantation), 3 days, 2 weeks
and 4 weeks after transplantation, respectively. At each
time point after MRI examination, myocardial tissue
from 6~8 hearts was analyzed by postmortem analyses.
Results
MR hypointensities caused by the MPIOs were detected
on T2*-weighted imaging at all times after MSCs trans-
plantation. As time progressed, the signal gradually wea-
kened and the area shrank. Serial cine-MRI showed that
MSCs transplantation attenuated progressive left ventri-
cular dilatation and dysfunction compared with controls
at 4 weeks. By real-time polymerase chain reaction with
Y-chromosome specific primers, the number of grafted
MSCs in the hearts decreased rapidly from 11.5%
(3 days) to ~0.1% (4 weeks). Double staining for iron
and CD68 (resident macrophage marker) showed that
most of the iron-positive cells were cardiac macrophages
at 4 weeks. In addition, MSC-treated hearts had signifi-
cantly increased capillary density in the peri-infarct
region, and lower cardiomyocytes apoptosis and collagen
deposition.
Conclusions
The survival of injected MPIO-labeled MSCs is poor at
4 weeks after transplantation, and the MR hypointensi-
ties mainly arise from cardiac macrophage that engulfed
the MPIO particles. However, MSCs attenuate left ven-
tricular dilatation and dysfunction after MI, which may
attribute to enhanced angiogenesis, inhibition of host
cell apoptosis and fibrosis.
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